hers semaglutide reddit The GLP-1 drug shortage is over. What's next for the compounders? - Pharma Technology Focus | Issue 154 Hims & Hers adds $49

Weight loss peptides represent one of the most significant advances in metabolic medicine in the past decade

the collection, management, analysis and interpretation of the data

Angry patients spur new state watchdogs to bring down drug prices But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients starting body mass index, or BMI

AK: Data curation, Formal Analysis, Investigation, Methodology, Validation, Writing review & editing